ReviewCurrent opinion in critical care2026
Personalized protein delivery in critical care: from phenotyping and endotyping to post-ICU recovery.
Review in Current opinion in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review examines the importance of optimizing protein delivery during and in the convalescence of critical illness, with a focus on the challenges associated with individual protein dosing strategies. RECENT
findingsMuscle mass depletion often begins within the first days of intensive care unit (ICU) admission, emphasizing the need for adequate protein intake. However, many ICU patients fail to meet recommended targets. Large-scale studies have shown mixed results on high-protein intake, with some suggesting no added benefit or even harm in certain groups. This review highlights the need for individualized protein dosing guided by phenotyping and endotyping and discusses the challenges in assessing body composition, illustrated by a case study. The potential role of biomarkers in optimizing protein dosing is also explored, alongside factors that hinder adequate protein intake. SUMMARY: Further research is needed to determine the optimal protein strategy for critically ill patients, with a focus on enhancing functional outcomes and quality of life, particularly for survivors who face long-term physical and cognitive challenges. Future guidelines should incorporate individualized approaches, leveraging emerging technologies and patient-centred data to tailor protein delivery and enhance recovery outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.